E
Enzene Biosciences
We are driven by the vision to positively impact the global healthcare landscape by delivering reliable and affordable medicines to improve life quality
About Enzene Biosciences
Enzene is a biotech startup based in India, specializing in the development of clinical and biosimilar products. The company has a robust pipeline of products that are on the brink of being launched in both the Indian and global markets. Enzene's business model revolves around B2B licensing opportunities, offering its innovative products to other businesses in the region.
The company is driven by a team of world-class scientists who are dedicated to making a significant impact on human lives. Their leadership team is highly experienced, with decades of experience in the pharmaceutical industry and recognition from industry bodies such as the Indian Drug Association.
Enzene operates in the biotech and pharmaceutical market, serving clients in the healthcare sector. They generate revenue through the sales of their products, with 32% of their revenue coming from offshore sales.
The company is also committed to maintaining high standards of environmental, health, and safety (EHS) performance. They regularly conduct inspections, audits, and reviews to ensure compliance with regulatory and company standards. They also invest in training and communication to raise awareness and develop knowledge about EHS issues.
Enzene is a subsidiary of Alkem, one of the top ten pharmaceutical companies in India. Alkem has a strong portfolio of over 800 brands and more than 1,300 SKUs across a wide range of therapy segments.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Dec 2025 | $33M | — | Alkem Laboratories | ↗ |
| LATE VCOther financing | Jan 2023 | $50M | $200M | Alkem Laboratories · Eight Roads Ventures · F-Prime | ↗ |
Growth signals
Latest recorded traffic for Enzene Biosciences is 23K monthly website visits, up 109.1% over the last three months. Enzene Biosciences's team grew 6.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Enzene Biosciences in the Pune ecosystem
The Enzene Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Alkem Laboratories
Eight Roads Ventures
F-Prime
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Enzene Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Enzene Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








